Medizinische Fachkräfte

Actions

PEBSI

Actions

Conclusion

Study Design

Prospective, multi-center, randomized, investigator-initiated trial to compare the efficacy and safety of the combined treatment of BMS plus DCB versus the conventional treatment (BMS only) in patients with STEMI within 12 hours of symptom onset. Baseline characteristics were similar in both groups

Primary Endpoint Result (9-month angiographic follow-up)

Secondary Endpoint Results

Downloads


${loading}